This federal contract award is for the delivery of Ketorolac 60 mg/2 ml vials (2 ml) to the Defense Logistics Agency (DLA), a defense agency. The contract was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, on December 6, 2024. The contract is a Delivery Order with a Firm Fixed Price pricing type, valued at $1,050.16. The contract has a completion date of December 9, 2024 and is not designated as a set-aside. Amerisourcebergen Drug Corp is the prime contractor, and this award is a part of a larger Indefinite Delivery Contract (IDC) the company holds with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This IDC serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally.
Generated 3/7/25, 10:01 AM